Status:
UNKNOWN
Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction
Lead Sponsor:
John Sievenpiper
Conditions:
Dyslipidemias
Cardiovascular Risk Factor
Eligibility:
All Genders
18+ years
Brief Summary
Although soy protein has approved health claims in Canada and the US, and is recognized by major cardiovascular clinical practice guidelines for the reduction of cholesterol and risk of coronary heart...
Detailed Description
RATIONALE. Although soy protein has approved health claims in Canada and the US and is recognized by major cardiovascular clinical practice guidelines for the reduction of cholesterol and risk of coro...
Eligibility Criteria
Inclusion
- Randomized controlled trials
- Soy protein (Isolated soy protein and non-isolated soy protein) intervention
- Non-soy protein containing comparator
- Intervention duration ≥ 3 weeks
- Data for at least 1 outcome
Exclusion
- Non-human studies
- Observational studies
- Acute single-bolus feeding studies
- Participants \<18 years of age
- Interventions of soy derivatives or extracts (i.e. soy oil, sterols, etc)
- No quantification of soy protein in intervention
- Multimodal interventions
- Lack of a suitable comparator (i.e. a comparator arm that contains soy protein)
- Intervention duration \< 3 weeks
- No viable outcome data
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04861545
Start Date
May 1 2021
End Date
May 15 2022
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital
Toronto, Ontario, Canada, M5C 2T2